{"transactions":[{"id":4243442,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":174016,"kind":"person","name":"WIGGINTON STEVE","position":1,"cik":"0001232583","reported_name":"WIGGINTON STEVE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, Valence Health"}}],"security":"Class A Common Stock Option (right to buy)","published_at":"2017-08-03T16:30:08.000Z","date":"2017-08-01","kind":"exercise","acquired":false,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 12, 2016."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Tbe Class A Common Stock Options exercised vested on October 1, 2014."}],"balance_after":399680,"derivative":{"exercise_price":3.84,"expiration_date":"2024-04-01","underlying":"Class A Common Stock","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0001628908-17-000038","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1232583/000162890817000038/primary_doc.xml","form_type":"4"}},{"id":4243441,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":174016,"kind":"person","name":"WIGGINTON STEVE","position":1,"cik":"0001232583","reported_name":"WIGGINTON STEVE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, Valence Health"}}],"security":"Class A Common Stock","published_at":"2017-08-03T16:30:08.000Z","date":"2017-08-01","kind":"sale","acquired":false,"shares":6000,"price":24.64,"value":147840.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 12, 2016."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average. These shares were sold in multiple transactions at prices ranging from $24.35-$24.90, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate prices within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted stock units under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission."}],"balance_after":12411,"source":{"system":"sec-edgar","filing":"0001628908-17-000038","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1232583/000162890817000038/primary_doc.xml","form_type":"4"}},{"id":4243440,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":174016,"kind":"person","name":"WIGGINTON STEVE","position":1,"cik":"0001232583","reported_name":"WIGGINTON STEVE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, Valence Health"}}],"security":"Class A Common Stock","published_at":"2017-08-03T16:30:08.000Z","date":"2017-08-01","kind":"exercise","acquired":true,"shares":6000,"price":3.84,"value":23040.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 12, 2016."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted stock units under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission."}],"balance_after":18411,"source":{"system":"sec-edgar","filing":"0001628908-17-000038","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232583/000162890817000038/primary_doc.xml","form_type":"4"}},{"id":4261613,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":174016,"kind":"person","name":"WIGGINTON STEVE","position":1,"cik":"0001232583","reported_name":"WIGGINTON STEVE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, Valence Health"}}],"security":"Class A Common Stock Option (right to buy)","published_at":"2017-07-06T16:27:09.000Z","date":"2017-07-03","kind":"exercise","acquired":false,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 12, 2016."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The Class A Common Stock Options exercised vested on October 1, 2014."}],"balance_after":405680,"derivative":{"exercise_price":3.84,"expiration_date":"2024-04-01","underlying":"Class A Common Stock","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0001628908-17-000034","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1232583/000162890817000034/primary_doc.xml","form_type":"4"}},{"id":4261612,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":174016,"kind":"person","name":"WIGGINTON STEVE","position":1,"cik":"0001232583","reported_name":"WIGGINTON STEVE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, Valence Health"}}],"security":"Class A Common Stock","published_at":"2017-07-06T16:27:09.000Z","date":"2017-07-03","kind":"sale","acquired":false,"shares":6000,"price":25.07,"value":150420.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 12, 2016."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average. These shares were sold in multiple transactions at prices ranging from $24.925-$25.275, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted stock units under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission."}],"balance_after":12411,"source":{"system":"sec-edgar","filing":"0001628908-17-000034","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1232583/000162890817000034/primary_doc.xml","form_type":"4"}},{"id":4261611,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":174016,"kind":"person","name":"WIGGINTON STEVE","position":1,"cik":"0001232583","reported_name":"WIGGINTON STEVE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, Valence Health"}}],"security":"Class A Common Stock","published_at":"2017-07-06T16:27:09.000Z","date":"2017-07-03","kind":"exercise","acquired":true,"shares":6000,"price":3.84,"value":23040.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 12, 2016."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted stock units under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission."}],"balance_after":18411,"source":{"system":"sec-edgar","filing":"0001628908-17-000034","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232583/000162890817000034/primary_doc.xml","form_type":"4"}},{"id":4288179,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":174016,"kind":"person","name":"WIGGINTON STEVE","position":1,"cik":"0001232583","reported_name":"WIGGINTON STEVE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, Valence Health"}}],"security":"Class A Common Stock","published_at":"2017-06-08T16:54:50.000Z","date":"2017-06-06","kind":"sale","acquired":false,"shares":959,"price":25.75,"value":24694.25,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 12, 2016."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted stock units under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission."}],"balance_after":12411,"source":{"system":"sec-edgar","filing":"0001232583-17-000007","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232583/000123258317000007/primary_doc.xml","form_type":"4"}},{"id":4292605,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":174016,"kind":"person","name":"WIGGINTON STEVE","position":1,"cik":"0001232583","reported_name":"WIGGINTON STEVE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, Valence Health"}}],"security":"Class A Common Stock Option (right to buy)","published_at":"2017-06-05T18:12:13.000Z","date":"2017-06-01","kind":"exercise","acquired":false,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 12, 2016."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The Class A Common Stock Options exercised vested on October 1, 2014."}],"balance_after":411680,"derivative":{"exercise_price":3.84,"expiration_date":"2024-04-01","underlying":"Class A Common Stock","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0001232583-17-000006","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1232583/000123258317000006/primary_doc.xml","form_type":"4"}},{"id":4292604,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":174016,"kind":"person","name":"WIGGINTON STEVE","position":1,"cik":"0001232583","reported_name":"WIGGINTON STEVE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, Valence Health"}}],"security":"Class A Common Stock","published_at":"2017-06-05T18:12:13.000Z","date":"2017-06-01","kind":"sale","acquired":false,"shares":4400,"price":24.36,"value":107184.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 12, 2016."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average. These shares were sold in multiple transactions at prices ranging from $24.00-$24.60, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted stock units under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission."}],"balance_after":13370,"source":{"system":"sec-edgar","filing":"0001232583-17-000006","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1232583/000123258317000006/primary_doc.xml","form_type":"4"}},{"id":4292603,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":174016,"kind":"person","name":"WIGGINTON STEVE","position":1,"cik":"0001232583","reported_name":"WIGGINTON STEVE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, Valence Health"}}],"security":"Class A Common Stock","published_at":"2017-06-05T18:12:13.000Z","date":"2017-06-01","kind":"sale","acquired":false,"shares":1600,"price":23.51,"value":37616.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 12, 2016."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average. These shares were sold in multiple transactions at prices ranging from $23.00-$23.85, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate prices within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted stock units under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission."}],"balance_after":17770,"source":{"system":"sec-edgar","filing":"0001232583-17-000006","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1232583/000123258317000006/primary_doc.xml","form_type":"4"}},{"id":4292602,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":174016,"kind":"person","name":"WIGGINTON STEVE","position":1,"cik":"0001232583","reported_name":"WIGGINTON STEVE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, Valence Health"}}],"security":"Class A Common Stock","published_at":"2017-06-05T18:12:13.000Z","date":"2017-06-01","kind":"exercise","acquired":true,"shares":6000,"price":3.84,"value":23040.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 12, 2016."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted stock units under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission."}],"balance_after":19370,"source":{"system":"sec-edgar","filing":"0001232583-17-000006","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232583/000123258317000006/primary_doc.xml","form_type":"4"}},{"id":4307905,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":174016,"kind":"person","name":"WIGGINTON STEVE","position":1,"cik":"0001232583","reported_name":"WIGGINTON STEVE","relationship":{"officer":true,"officer_title":"CEO, Valence Health"}}],"security":"Class A Common Stock","published_at":"2017-05-23T18:29:15.000Z","date":"2017-05-19","kind":"sale","acquired":false,"shares":13640,"price":24.3,"value":331452.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes restricted stock units under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission."}],"balance_after":13370,"source":{"system":"sec-edgar","filing":"0000950157-17-000723","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232583/000095015717000723/form4.xml","form_type":"4"}},{"id":4334911,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":174016,"kind":"person","name":"WIGGINTON STEVE","position":1,"cik":"0001232583","reported_name":"WIGGINTON STEVE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, Valence Health"}}],"security":"Class A Common Stock Option (right to buy)","published_at":"2017-05-03T17:04:49.000Z","date":"2017-05-01","kind":"exercise","acquired":false,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 12, 2016."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Class A Common Stock Options exercised began vesting at a rate of 25% annually beginning October 1, 2014."}],"balance_after":417680,"derivative":{"exercise_price":3.84,"expiration_date":"2024-04-01","underlying":"Class A Common Stock","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0001232583-17-000005","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1232583/000123258317000005/primary_doc.xml","form_type":"4"}},{"id":4334910,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":174016,"kind":"person","name":"WIGGINTON STEVE","position":1,"cik":"0001232583","reported_name":"WIGGINTON STEVE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, Valence Health"}}],"security":"Class A Common Stock","published_at":"2017-05-03T17:04:49.000Z","date":"2017-05-01","kind":"sale","acquired":false,"shares":6000,"price":23.1,"value":138600.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 12, 2016."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average. These shares were sold in multiple transactions at prices ranging from $22.90-$23.35, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":358704,"source":{"system":"sec-edgar","filing":"0001232583-17-000005","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1232583/000123258317000005/primary_doc.xml","form_type":"4"}},{"id":4334909,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":174016,"kind":"person","name":"WIGGINTON STEVE","position":1,"cik":"0001232583","reported_name":"WIGGINTON STEVE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, Valence Health"}}],"security":"Class A Common Stock","published_at":"2017-05-03T17:04:49.000Z","date":"2017-05-01","kind":"exercise","acquired":true,"shares":6000,"price":3.84,"value":23040.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 12, 2016."}],"balance_after":364704,"source":{"system":"sec-edgar","filing":"0001232583-17-000005","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232583/000123258317000005/primary_doc.xml","form_type":"4"}},{"id":4357881,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":174016,"kind":"person","name":"WIGGINTON STEVE","position":1,"cik":"0001232583","reported_name":"WIGGINTON STEVE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, Valence Health"}}],"security":"Class A Common Stock Option (right to buy)","published_at":"2017-04-05T19:00:28.000Z","date":"2017-04-03","kind":"exercise","acquired":false,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 12, 2016."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The Class A Common Stock Options exercised began vesting at a rate of 25% annually beginning October 1, 2014."}],"balance_after":423680,"derivative":{"exercise_price":3.84,"expiration_date":"2024-04-01","underlying":"Class A Common Stock","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0001232583-17-000004","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1232583/000123258317000004/primary_doc.xml","form_type":"4"}},{"id":4357880,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":174016,"kind":"person","name":"WIGGINTON STEVE","position":1,"cik":"0001232583","reported_name":"WIGGINTON STEVE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, Valence Health"}}],"security":"Class A Common Stock","published_at":"2017-04-05T19:00:28.000Z","date":"2017-04-03","kind":"sale","acquired":false,"shares":700,"price":23.41,"value":16387.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 12, 2016."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average. These shares were sold in multiple transactions at prices ranging from $23.40-$23.45, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":358704,"source":{"system":"sec-edgar","filing":"0001232583-17-000004","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1232583/000123258317000004/primary_doc.xml","form_type":"4"}},{"id":4357879,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":174016,"kind":"person","name":"WIGGINTON STEVE","position":1,"cik":"0001232583","reported_name":"WIGGINTON STEVE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, Valence Health"}}],"security":"Class A Common Stock","published_at":"2017-04-05T19:00:28.000Z","date":"2017-04-03","kind":"sale","acquired":false,"shares":5300,"price":23.11,"value":122483.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 12, 2016."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average. These shares were sold in multiple transactions at prices ranging from $22.375-$23.375, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":359404,"source":{"system":"sec-edgar","filing":"0001232583-17-000004","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1232583/000123258317000004/primary_doc.xml","form_type":"4"}},{"id":4357878,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":174016,"kind":"person","name":"WIGGINTON STEVE","position":1,"cik":"0001232583","reported_name":"WIGGINTON STEVE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, Valence Health"}}],"security":"Class A Common Stock","published_at":"2017-04-05T19:00:28.000Z","date":"2017-04-03","kind":"exercise","acquired":true,"shares":6000,"price":3.84,"value":23040.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 12, 2016."}],"balance_after":364704,"source":{"system":"sec-edgar","filing":"0001232583-17-000004","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232583/000123258317000004/primary_doc.xml","form_type":"4"}},{"id":4397002,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":174016,"kind":"person","name":"WIGGINTON STEVE","position":1,"cik":"0001232583","reported_name":"WIGGINTON STEVE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, Valence Health"}}],"security":"Class A Common Stock","published_at":"2017-03-07T17:20:41.000Z","date":"2017-03-03","kind":"sale","acquired":false,"shares":988,"price":20.2,"value":19957.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 12, 2016."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average. These shares were sold in multiple transactions at prices ranging from $19.80-$20.45, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":358704,"source":{"system":"sec-edgar","filing":"0001232583-17-000003","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232583/000123258317000003/primary_doc.xml","form_type":"4"}},{"id":4403128,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":174016,"kind":"person","name":"WIGGINTON STEVE","position":1,"cik":"0001232583","reported_name":"WIGGINTON STEVE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, Valence Health"}}],"security":"Class A Common Stock Option (right to buy)","published_at":"2017-03-03T16:43:28.000Z","date":"2017-03-01","kind":"exercise","acquired":false,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 12, 2016."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Class A Common Stock Options exercised began vesting at a rate of 25% annually beginning October 1, 2014."}],"balance_after":429680,"derivative":{"exercise_price":3.84,"expiration_date":"2024-04-01","underlying":"Class A Common Stock","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0001232583-17-000002","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1232583/000123258317000002/primary_doc.xml","form_type":"4"}},{"id":4403127,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":174016,"kind":"person","name":"WIGGINTON STEVE","position":1,"cik":"0001232583","reported_name":"WIGGINTON STEVE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, Valence Health"}}],"security":"Class A Common Stock","published_at":"2017-03-03T16:43:28.000Z","date":"2017-03-01","kind":"sale","acquired":false,"shares":6000,"price":20.11,"value":120660.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 12, 2016."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average. These shares wee sold in multiple transactions at prices ranging from $20.00-$20.325, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":359692,"source":{"system":"sec-edgar","filing":"0001232583-17-000002","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1232583/000123258317000002/primary_doc.xml","form_type":"4"}},{"id":4403126,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":174016,"kind":"person","name":"WIGGINTON STEVE","position":1,"cik":"0001232583","reported_name":"WIGGINTON STEVE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, Valence Health"}}],"security":"Class A Common Stock","published_at":"2017-03-03T16:43:28.000Z","date":"2017-03-01","kind":"exercise","acquired":true,"shares":6000,"price":3.84,"value":23040.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 12, 2016."}],"balance_after":365692,"source":{"system":"sec-edgar","filing":"0001232583-17-000002","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232583/000123258317000002/primary_doc.xml","form_type":"4"}},{"id":4438903,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":174016,"kind":"person","name":"WIGGINTON STEVE","position":1,"cik":"0001232583","reported_name":"WIGGINTON STEVE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, Valence Health"}}],"security":"Class A Common Stock (right to buy)","published_at":"2017-02-17T18:17:16.000Z","date":"2017-02-15","kind":"exercise","acquired":false,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 12, 2016."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The Class A Common Stock Options exercised began vesting at a rate of 25% annually beginning October 1, 2014."}],"balance_after":435680,"derivative":{"exercise_price":3.84,"expiration_date":"2024-04-01","underlying":"Class A Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001232583-17-000001","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1232583/000123258317000001/primary_doc.xml","form_type":"4"}},{"id":4438902,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":174016,"kind":"person","name":"WIGGINTON STEVE","position":1,"cik":"0001232583","reported_name":"WIGGINTON STEVE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, Valence Health"}}],"security":"Class A Common Stock","published_at":"2017-02-17T18:17:16.000Z","date":"2017-02-15","kind":"sale","acquired":false,"shares":6000,"price":20.13,"value":120780.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 12, 2016."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average. These shares were sold in multiple transactions at prices ranging from $20.00-$20.25, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":359692,"source":{"system":"sec-edgar","filing":"0001232583-17-000001","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1232583/000123258317000001/primary_doc.xml","form_type":"4"}},{"id":4438901,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":174016,"kind":"person","name":"WIGGINTON STEVE","position":1,"cik":"0001232583","reported_name":"WIGGINTON STEVE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, Valence Health"}}],"security":"Class A Common Stock","published_at":"2017-02-17T18:17:16.000Z","date":"2017-02-15","kind":"sale","acquired":false,"shares":6000,"price":20.12,"value":120720.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 12, 2016."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average. These shares were sold in multiple transactions at prices ranging from $20.00-$20.25, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":365692,"source":{"system":"sec-edgar","filing":"0001232583-17-000001","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1232583/000123258317000001/primary_doc.xml","form_type":"4"}},{"id":4438900,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":174016,"kind":"person","name":"WIGGINTON STEVE","position":1,"cik":"0001232583","reported_name":"WIGGINTON STEVE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, Valence Health"}}],"security":"Class A Common Stock","published_at":"2017-02-17T18:17:16.000Z","date":"2017-02-15","kind":"exercise","acquired":true,"shares":12000,"price":3.84,"value":46080.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 12, 2016."}],"balance_after":371692,"source":{"system":"sec-edgar","filing":"0001232583-17-000001","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232583/000123258317000001/primary_doc.xml","form_type":"4"}},{"id":4602466,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":174016,"kind":"person","name":"WIGGINTON STEVE","position":1,"cik":"0001232583","reported_name":"WIGGINTON STEVE","relationship":{"officer":true,"officer_title":"Chief Development Officer"}}],"security":"Class A Common Stock","published_at":"2016-09-15T16:56:49.000Z","date":"2016-09-14","kind":"sale","acquired":false,"shares":45760,"price":21.54,"value":985670.4,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price of $21.54 represents the public offering price of $22.50 per share of Class A Common Stock less the underwriters' discount of $0.96 per share."}],"balance_after":359692,"source":{"system":"sec-edgar","filing":"0000950157-16-002181","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232583/000095015716002181/form4.xml","form_type":"4"}}]}